PATENT CLAIM ANALYSIS

Application Number: 15765756
Application Type: Utility
Filing Date: 2018-04
Publication Date: 2018-10
Patent Classification: ["514", "171000"]

Abstract:
The present invention relates to methods and pharmaceutical compositions for the treatment of choroidal neovascularisation. In particular, the present invention relates to a method of treating choroidal neovascularisation in a subject in need thereof comprising administering to the subject a therapeutically effective amount of a mineralocorticoid receptor antagonist.

Claim (Index 8):
The method of  claim 1  wherein the MR antagonist is administered to the subject in combination with an anti-VEGF agent.

Metadata:
- Claim Count in Document: 5.0
- Percentile: 91.0
- Lexical Diversity: 1.5
- Patent Class: 514.0
- Transitional Phrase Type: none
- Component Type: 0
- Foreign Priority: True
- Related Applications: ['14899162', '15616971', '11199374', '12457478', '14436727']

Analysis Scores:
- 35 USC 101 Eligibility (BERT): 0.7845216921547945
- 35 USC 102 Novelty (BERT): 0.5250989198689076
- Combined Prediction Score: 0.7585794149262057
- Mean Citation Score: 277.300696
- Max Citation Score: 323.35165
- Similarity Product: 214.64265659976897

Labels:
- Claim Label 101: 1
- Claim Label 102: 1
- Claim Label 103: 1
- Claim Label 112: 1
- Combined Label: 1
- Label 101 Adjusted: 1

Dataset: test